Development of an anti- Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244.

Autor: Horspool AM; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Sen-Kilic E; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Malkowski AC; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Breslow SL; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Mateu-Borras M; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Hudson MS; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Nunley MA; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Elliott S; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Ray K; University of Maryland, Baltimore School of Medicine, Division of Vaccine Research, Institute of Human Virology, Baltimore, MD, United States., Snyder GA; University of Maryland, Baltimore School of Medicine, Division of Vaccine Research, Institute of Human Virology, Baltimore, MD, United States., Miller SJ; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Kang J; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Blackwood CB; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Weaver KL; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Witt WT; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Huckaby AB; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Pyles GM; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Clark T; Department of Pediatrics, Division of Cystic Fibrosis, West Virginia University, Morgantown, WV, United States., Al Qatarneh S; Department of Pediatrics, Division of Cystic Fibrosis, West Virginia University, Morgantown, WV, United States., Lewis GK; University of Maryland, Baltimore School of Medicine, Division of Vaccine Research, Institute of Human Virology, Baltimore, MD, United States., Damron FH; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States., Barbier M; Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.; Vaccine Development Center, West Virginia University Health Sciences Center, Morgantown, WV, United States.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Apr 14; Vol. 13, pp. 1117844. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).